Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ORBION PHARMS

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 56
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 53
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; SPIRONOLACTONE

Comment Full text

ORBION PHARMS

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 65
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 55
  • 0 comments

FDA approve CELECOXIB

Comment Full text

GRANULES

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 53
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

BRIGHTGENE

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 67
  • 0 comments

FDA approve FONDAPARINUX SODIUM

Comment Full text

HIKMA

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 62
  • 0 comments

FDA approve PHYTONADIONE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 50
  • 0 comments

FDA approve PIRFENIDONE

Comment Full text

GLAND PHARMA LTD

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 62
  • 0 comments

FDA approve PHENYLEPHRINE HYDROCHLORIDE

Comment Full text

HENGRUI PHARMA

  • FDA Approval
  • Dec. 20, 2024, 09:42 UTC
  • 45
  • 0 comments

FDA approve IODIXANOL

Comment Full text
  • Previous
  • 270
  • 271
  • 272
  • 273
  • 274
  • Next

Search

News categories

  • Technical Exchange News(11448)
  • Event(3139)
  • SEC News(210823)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(136300)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin